Martingale Asset Management L P purchased a new stake in Tivity Health Inc (NASDAQ:TVTY) during the fourth quarter, Holdings Channel reports. The institutional investor purchased 22,300 shares of the company’s stock, valued at approximately $554,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in TVTY. Victory Capital Management Inc. raised its stake in Tivity Health by 327.0% during the third quarter. Victory Capital Management Inc. now owns 16,445 shares of the company’s stock worth $529,000 after acquiring an additional 12,594 shares in the last quarter. Wells Fargo & Company MN raised its stake in Tivity Health by 2.2% during the third quarter. Wells Fargo & Company MN now owns 1,175,870 shares of the company’s stock worth $37,804,000 after acquiring an additional 25,326 shares in the last quarter. Stone Ridge Asset Management LLC acquired a new position in Tivity Health during the third quarter worth $213,000. JPMorgan Chase & Co. raised its stake in Tivity Health by 91.3% during the third quarter. JPMorgan Chase & Co. now owns 2,545,523 shares of the company’s stock worth $81,838,000 after acquiring an additional 1,214,918 shares in the last quarter. Finally, Prudential Financial Inc. raised its stake in Tivity Health by 13.4% during the third quarter. Prudential Financial Inc. now owns 66,192 shares of the company’s stock worth $2,128,000 after acquiring an additional 7,810 shares in the last quarter.
Several analysts have recently commented on TVTY shares. Zacks Investment Research cut Tivity Health from a “buy” rating to a “hold” rating in a report on Saturday, November 17th. TheStreet cut Tivity Health from a “b” rating to a “c+” rating in a report on Wednesday, January 9th. BidaskClub cut Tivity Health from a “sell” rating to a “strong sell” rating in a report on Monday. ValuEngine cut Tivity Health from a “sell” rating to a “strong sell” rating in a report on Monday, January 7th. Finally, Oppenheimer decreased their target price on Tivity Health from $44.00 to $34.00 and set an “outperform” rating on the stock in a report on Tuesday, December 11th. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and seven have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $32.25.
Tivity Health (NASDAQ:TVTY) last announced its earnings results on Tuesday, February 19th. The company reported $0.73 EPS for the quarter, topping the consensus estimate of $0.57 by $0.16. The company had revenue of $153.04 million for the quarter, compared to analysts’ expectations of $153.66 million. Tivity Health had a return on equity of 30.19% and a net margin of 16.30%. As a group, equities analysts predict that Tivity Health Inc will post 2.33 EPS for the current year.
WARNING: This report was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://www.tickerreport.com/banking-finance/4223749/22300-shares-in-tivity-health-inc-tvty-purchased-by-martingale-asset-management-l-p.html.
Tivity Health Company Profile
Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers.
Read More: 12b-1 Fees
Want to see what other hedge funds are holding TVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tivity Health Inc (NASDAQ:TVTY).
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.